Pharmaceutical Executive-09-04-2008

News Analysis
Pharmaceutical Executive

September 04, 2008

After a year of layoffs and restructuring, Valeant Pharma scores big with a collaboration deal worth up to $670 million.

News Analysis
Pharmaceutical Executive

September 04, 2008

The Belgium-based drug maker is terminating 2,000 jobs and rebranding itself as a biopharm with a focus on CNS and immunology drugs. Pharm Exec gave UCB a call to find out more.